BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Nakamura M, Abe Y, Tokunaga T. Pathological significance of vascular endothelial growth factor A isoform expression in human cancer. Pathol Int. 2002;52:331-339. [PMID: 12100515 DOI: 10.1046/j.1440-1827.2002.01367.x] [Cited by in Crossref: 35] [Cited by in F6Publishing: 29] [Article Influence: 1.9] [Reference Citation Analysis]
Number Citing Articles
1 Yen P, Finley SD, Engel-Stefanini MO, Popel AS. A two-compartment model of VEGF distribution in the mouse. PLoS One 2011;6:e27514. [PMID: 22087332 DOI: 10.1371/journal.pone.0027514] [Cited by in Crossref: 27] [Cited by in F6Publishing: 24] [Article Influence: 2.7] [Reference Citation Analysis]
2 Martín-Beltrán C, Sánchez-Peris M, Conesa-Milián L, Falomir E, Murga J, Carda M, Marco JA. Arylpyridines, arylpyrimidines and related compounds as potential modulator agents of the VEGF, hTERT and c-Myc oncogenes. Bioorg Med Chem 2019;27:880-7. [PMID: 30733086 DOI: 10.1016/j.bmc.2019.01.039] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
3 Huang G, Zhou Z, Wang H, Kleinerman ES. CAPER-α alternative splicing regulates the expression of vascular endothelial growth factor₁₆₅ in Ewing sarcoma cells. Cancer 2012;118:2106-16. [PMID: 22009261 DOI: 10.1002/cncr.26488] [Cited by in Crossref: 34] [Cited by in F6Publishing: 35] [Article Influence: 3.4] [Reference Citation Analysis]
4 Kwon HC, Oh SY, Lee S, Kim SH, Kim HJ. Bevacizumab plus infusional 5-fluorouracil, leucovorin and irinotecan for advanced colorectal cancer that progressed after oxaliplatin and irinotecan chemotherapy: a pilot study. World J Gastroenterol. 2007;13:6231-6235. [PMID: 18069765 DOI: 10.3748/wjg.13.6231] [Cited by in CrossRef: 10] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
5 Ricci AG, Olivares CN, Bilotas MA, Meresman GF, Barañao RI. Effect of Vascular Endothelial Growth Factor Inhibition on Endometrial Implant Development in a Murine Model of Endometriosis. Reprod Sci 2011;18:614-22. [DOI: 10.1177/1933719110395406] [Cited by in Crossref: 67] [Cited by in F6Publishing: 62] [Article Influence: 6.7] [Reference Citation Analysis]
6 Shan B, Gao C, Chen JM, Bi XY, Zhang BY, Guo Y, Dong CF, An R, Shi Q, Hu JQ, Zhao P, Han J, Dong XP. Establishment of a sandwich ELISA method for detection of vascular endothelial growth factor in serum samples of hepatocellular carcinoma patients. Biomed Environ Sci 2008;21:69-74. [PMID: 18478981 DOI: 10.1016/S0895-3988(08)60009-4] [Reference Citation Analysis]
7 Kanthou C, Dachs GU, Lefley DV, Steele AJ, Coralli-Foxon C, Harris S, Greco O, Dos Santos SA, Reyes-Aldasoro CC, English WR, Tozer GM. Tumour cells expressing single VEGF isoforms display distinct growth, survival and migration characteristics. PLoS One 2014;9:e104015. [PMID: 25119572 DOI: 10.1371/journal.pone.0104015] [Cited by in Crossref: 13] [Cited by in F6Publishing: 7] [Article Influence: 1.9] [Reference Citation Analysis]
8 Martí-Centelles R, Falomir E, Murga J, Carda M, Marco JA. Inhibitory effect of cytotoxic stilbenes related to resveratrol on the expression of the VEGF, hTERT and c-Myc genes. Eur J Med Chem 2015;103:488-96. [PMID: 26402726 DOI: 10.1016/j.ejmech.2015.09.014] [Cited by in Crossref: 19] [Cited by in F6Publishing: 13] [Article Influence: 3.2] [Reference Citation Analysis]
9 Mataftsi A, Dimitrakos SA, Adams GG. Mediators involved in retinopathy of prematurity and emerging therapeutic targets. Early Hum Dev 2011;87:683-90. [PMID: 21700404 DOI: 10.1016/j.earlhumdev.2011.05.009] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 1.5] [Reference Citation Analysis]
10 Al Balawi IA, Mir R, Abu-Duhier FM. Potential Impact of Vascular Endothelial Growth Factor Gene Variation (-2578C>A) on Breast Cancer Susceptibility in Saudi Arabia: a Case-Control Study. Asian Pac J Cancer Prev 2018;19:1135-43. [PMID: 29699375 DOI: 10.22034/APJCP.2018.19.4.1135] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
11 Elias AP, Dias S. Microenvironment changes (in pH) affect VEGF alternative splicing. Cancer Microenviron. 2008;1:131-139. [PMID: 19308691 DOI: 10.1007/s12307-008-0013-4] [Cited by in Crossref: 39] [Cited by in F6Publishing: 33] [Article Influence: 3.0] [Reference Citation Analysis]
12 Lin YC, Yeh CJ, Wang LH, Lee CW, Chen CH. The effect of CCND1 +870A>G and VEGF +936C>T polymorphisms on oral cancer development and disease-free survival in a Taiwan population. Oral Oncol 2012;48:535-40. [PMID: 22321253 DOI: 10.1016/j.oraloncology.2012.01.008] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.2] [Reference Citation Analysis]
13 Herrmann J, Lerman LO, Mukhopadhyay D, Napoli C, Lerman A. Angiogenesis in Atherogenesis. ATVB 2006;26:1948-57. [DOI: 10.1161/01.atv.0000233387.90257.9b] [Cited by in Crossref: 88] [Cited by in F6Publishing: 33] [Article Influence: 5.9] [Reference Citation Analysis]
14 Lim TY, Poh CK, Wang W. Poly (lactic-co-glycolic acid) as a controlled release delivery device. J Mater Sci: Mater Med 2009;20:1669-75. [DOI: 10.1007/s10856-009-3727-z] [Cited by in Crossref: 32] [Cited by in F6Publishing: 22] [Article Influence: 2.7] [Reference Citation Analysis]
15 Roodink I, van der Laak J, Kusters B, Wesseling P, Verrijp K, de Waal R, Leenders W. Development of the tumor vascular bed in response to hypoxia-induced VEGF-A differs from that in tumors with constitutive VEGF-A expression: Vascular Phenotypes in Tumors with Hypoxic vs Genetic VEGF-A Expression. Int J Cancer 2006;119:2054-62. [DOI: 10.1002/ijc.22072] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 1.4] [Reference Citation Analysis]
16 Rezaei M, Hashemi M, Sanaei S, Mashhadi MA, Taheri M. Association Between Vascular Endothelial Growth Factor Gene Polymorphisms with Breast Cancer Risk in an Iranian Population. Breast Cancer (Auckl) 2016;10:85-91. [PMID: 27398026 DOI: 10.4137/BCBCR.S39649] [Cited by in Crossref: 4] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
17 Wågsäter D, Löfgren S, Zar N, Hugander A, Dimberg J. Pigment epithelium-derived factor expression in colorectal cancer patients. Cancer Invest 2010;28:872-7. [PMID: 20504225 DOI: 10.3109/07357901003735675] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
18 Dimberg J, Ström K, Löfgren S, Zar N, Lindh M, Matussek A. DNA promoter methylation status and protein expression of interleukin-8 in human colorectal adenocarcinomas. Int J Colorectal Dis 2012;27:709-14. [PMID: 22108905 DOI: 10.1007/s00384-011-1367-5] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 2.1] [Reference Citation Analysis]
19 Kidd LR, Brock GN, VanCleave TT, Benford ML, Lavender NA, Kruer TL, Wittliff JL. Angiogenesis-associated sequence variants relative to breast cancer recurrence and survival. Cancer Causes Control 2010;21:1545-57. [PMID: 20571871 DOI: 10.1007/s10552-010-9583-9] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 1.2] [Reference Citation Analysis]
20 Mandal RK, Yadav SS, Panda AK, Khattri S. Vascular endothelial growth factor 936 c>T polymorphism increased oral cancer risk: evidence from a meta-analysis. Genet Test Mol Biomarkers 2013;17:543-7. [PMID: 23586368 DOI: 10.1089/gtmb.2013.0020] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 1.4] [Reference Citation Analysis]
21 Poh CK, Shi Z, Lim TY, Neoh KG, Wang W. The effect of VEGF functionalization of titanium on endothelial cells in vitro. Biomaterials 2010;31:1578-85. [DOI: 10.1016/j.biomaterials.2009.11.042] [Cited by in Crossref: 176] [Cited by in F6Publishing: 157] [Article Influence: 16.0] [Reference Citation Analysis]
22 Roche E, Lascombe I, Bittard H, Mougin C, Fauconnet S. The PPARβ agonist L-165041 promotes VEGF mRNA stabilization in HPV18-harboring HeLa cells through a receptor-independent mechanism. Cell Signal 2014;26:433-43. [PMID: 24172859 DOI: 10.1016/j.cellsig.2013.10.006] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
23 Kwon HC, Oh SY, Lee S, Kim SH, Kim HJ. Bevacizumab plus infusional 5-fluorouracil, leucovorin and irinotecan for advanced colorectal cancer that progressed after oxaliplatin and irinotecan chemotherapy: a pilot study. World J Gastroenterol 2007;13:6231-5. [PMID: 18069765 DOI: 10.3748/wjg.v13.i46.6231] [Cited by in CrossRef: 5] [Cited by in F6Publishing: 12] [Article Influence: 0.4] [Reference Citation Analysis]
24 Bartoli M, Platt D, Lemtalsi T, Gu X, Brooks SE, Marrero MB, Caldwell RB. VEGF differentially activates STAT3 in microvascular endothelial cells. FASEB J 2003;17:1562-4. [PMID: 12824281 DOI: 10.1096/fj.02-1084fje] [Cited by in Crossref: 109] [Cited by in F6Publishing: 101] [Article Influence: 6.1] [Reference Citation Analysis]
25 Chen S, Chen A, Huang C, Qian Y, Liu Z, Wu Y, Tu Y. Establishment of lymphangioma model and a study on the promoting effect of murine melanoma cell B16-F1 on the lymphangiogenesis in vitro. J Huazhong Univ Sci Technol [Med Sci ] 2007;27:733-5. [DOI: 10.1007/s11596-007-0630-z] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
26 Ma J, Hu W, Zhang P, Sun Y, Wang N, Teng X, Qiao Q. The Association Between VEGF +936C/T and -634G/C Polymorphisms and Breast Cancer Susceptibility, Tumor Growth, and Metastases: Evidence From 20,728 Subjects. Cancer Invest 2015;33:312-7. [PMID: 26067906 DOI: 10.3109/07357907.2015.1044664] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
27 Lamalice L, Houle F, Jourdan G, Huot J. Phosphorylation of tyrosine 1214 on VEGFR2 is required for VEGF-induced activation of Cdc42 upstream of SAPK2/p38. Oncogene 2004;23:434-45. [DOI: 10.1038/sj.onc.1207034] [Cited by in Crossref: 149] [Cited by in F6Publishing: 132] [Article Influence: 8.8] [Reference Citation Analysis]
28 Sánchez-peris M, Murga J, Falomir E, Carda M, Marco JA. Synthesis of honokiol analogues and evaluation of their modulating action on VEGF protein secretion and telomerase-related gene expressions. Chem Biol Drug Des 2017;89:577-84. [DOI: 10.1111/cbdd.12880] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.4] [Reference Citation Analysis]
29 Vilanova C, Díaz-oltra S, Murga J, Falomir E, Carda M, Marco JA. Inhibitory effect of pironetin analogue/colchicine hybrids on the expression of the VEGF, hTERT and c-Myc genes. Bioorganic & Medicinal Chemistry Letters 2015;25:3194-8. [DOI: 10.1016/j.bmcl.2015.05.092] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]